Growth Metrics

Quest Diagnostics (DGX) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $2.16.

  • Quest Diagnostics' EPS (Weighted Average and Diluted) rose 8.54% to $2.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.52, marking a year-over-year increase of 14.52%. This contributed to the annual value of $7.69 for FY2024, which is 2.67% up from last year.
  • Quest Diagnostics' EPS (Weighted Average and Diluted) amounted to $2.16 in Q3 2025, which was down 12.55% from $2.47 recorded in Q2 2025.
  • Quest Diagnostics' EPS (Weighted Average and Diluted)'s 5-year high stood at $4.96 during Q2 2021, with a 5-year trough of $0.92 in Q4 2022.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $1.98, with a median of $1.96 in 2023.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 373.97% in 2021, then crashed by 70.70% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' EPS (Weighted Average and Diluted) stood at $3.14 in 2021, then slumped by 70.70% to $0.92 in 2022, then surged by 84.78% to $1.70 in 2023, then rose by 14.71% to $1.95 in 2024, then climbed by 8.54% to $2.16 in 2025.
  • Its EPS (Weighted Average and Diluted) was $2.16 in Q3 2025, compared to $2.47 in Q2 2025 and $1.94 in Q1 2025.